BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26044547)

  • 21. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
    Ihenetu K; Molleman A; Parsons ME; Whelan CJ
    Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
    Gamage TF; Ignatowska-Jankowska BM; Wiley JL; Abdelrahman M; Trembleau L; Greig IR; Thakur GA; Tichkule R; Poklis J; Ross RA; Pertwee RG; Lichtman AH
    Behav Pharmacol; 2014 Apr; 25(2):182-5. PubMed ID: 24603340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):88-94. PubMed ID: 15626718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
    Smith SR; Terminelli C; Denhardt G
    J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor.
    Ahn KH; Mahmoud MM; Samala S; Lu D; Kendall DA
    J Neurochem; 2013 Mar; 124(5):584-9. PubMed ID: 23205875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of structurally novel G protein biased CB
    Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
    Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP; Kraichely DM; Wilken GH; Howlett AC
    Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
    Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
    Gessa GL; Mascia MS; Casu MA; Carta G
    Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.
    Smith SR; Terminelli C; Denhardt G
    Eur J Pharmacol; 2001 Aug; 425(1):73-83. PubMed ID: 11672577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
    Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.
    Carney ST; Lloyd ML; MacKinnon SE; Newton DC; Jones JD; Howlett AC; Norford DC
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):338-49. PubMed ID: 19365734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2.
    Marcu J; Shore DM; Kapur A; Trznadel M; Makriyannis A; Reggio PH; Abood ME
    J Pharmacol Exp Ther; 2013 May; 345(2):189-97. PubMed ID: 23426954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
    Dhopeshwarkar AS; Nicholson RA
    Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.